Seaport Therapeutics Secures $225M for New Kind of Depression Drug
MedCity News
OCTOBER 27, 2024
Seaport Therapeutics’ Series B financing was one of the largest rounds of funding in our recap of biotech financing news, which spans startups developing drugs for neurological diseases, cancer, immunology, and more. The post Seaport Therapeutics Secures $225M for New Kind of Depression Drug appeared first on MedCity News.
Let's personalize your content